Myocardial adipose triglyceride lipase overexpression protects diabetic mice from the development of lipotoxic cardiomyopathy.
about
Metabolic Remodeling in Diabetic Cardiomyopathy.Deficiency of a lipid droplet protein, perilipin 5, suppresses myocardial lipid accumulation, thereby preventing type 1 diabetes-induced heart malfunctionMitochondrial and cellular mechanisms for managing lipid excess.ATGL-catalyzed lipolysis regulates SIRT1 to control PGC-1α/PPAR-α signalingTargeting metabolic disturbance in the diabetic heart.Evidence for distinct effects of exercise in different cardiac hypertrophic disorders.Molecular Mechanisms of Retinoid Receptors in Diabetes-Induced Cardiac Remodeling.Enhancing Cardiac Triacylglycerol Metabolism Improves Recovery From Ischemic Stress.RNASET2 is required for ROS propagation during oxidative stress-mediated cell death.Comparative proteomics reveals abnormal binding of ATGL and dysferlin on lipid droplets from pressure overload-induced dysfunctional rat heartsEarly structural and metabolic cardiac remodelling in response to inducible adipose triglyceride lipase ablation.Skeletal muscle triacylglycerol hydrolysis does not influence metabolic complications of obesity.Good and bad consequences of altered fatty acid metabolism in heart failure: evidence from mouse models.Pyruvate dehydrogenase as a therapeutic target for obesity cardiomyopathy.Expression of lipogenic genes is upregulated in the heart with exercise training-induced but not pressure overload-induced left ventricular hypertrophy.Cardiac-specific adipose triglyceride lipase overexpression protects from cardiac steatosis and dilated cardiomyopathy following diet-induced obesity.The Role of Diacylglycerol Acyltransferase (DGAT) 1 and 2 in Cardiac Metabolism and Function.Coronary triglyceride deposition in contemporary advanced diabetics
P2860
Q33623469-2F224FAE-178E-4E4F-8102-7CBA751565B3Q33899819-0092BC64-EFC2-4B7A-98D2-912DE1722433Q33978623-E48DC124-0319-4070-9277-E08FB2FECEC9Q35004298-76829E4D-FB00-432A-A049-FCAA4614D5FCQ35084845-768F58C6-59CB-4FA5-8346-3D01A76E7435Q35117452-516626C9-C41C-4403-A2EA-48AA93AF83D4Q35667311-55374D08-6003-4F88-8961-DDCC6D3B9252Q35881763-0975DDF8-80A1-4E83-A2D1-254CC64A6508Q36472445-B4B5FB2A-C0D8-48EE-8259-DAC85DD9DECFQ36501131-EAC4AD9C-490D-400E-ACFB-9D6054590BD6Q37032295-3CAFF826-C305-43E7-8302-B6D284CC0B34Q37193401-4F32D28D-F4C7-485E-A353-9823173BE4E2Q38375945-60EF2DD0-388E-47A6-98F6-78901F5A6427Q38652550-D8F8BA7B-77DA-432F-982B-64AE45EBD6E2Q39427371-712E03AE-692C-4E91-B056-B8ED696DA6C8Q43821283-8601786C-6731-4744-AF6D-A0BAB1E812F8Q55192060-888ED7F1-14D0-407A-A982-EA3829E687DEQ57256740-12D603EC-A0B1-4476-ADD5-479729D4A172
P2860
Myocardial adipose triglyceride lipase overexpression protects diabetic mice from the development of lipotoxic cardiomyopathy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Myocardial adipose triglycerid ...... t of lipotoxic cardiomyopathy.
@en
type
label
Myocardial adipose triglycerid ...... t of lipotoxic cardiomyopathy.
@en
prefLabel
Myocardial adipose triglycerid ...... t of lipotoxic cardiomyopathy.
@en
P2093
P2860
P50
P356
P1433
P1476
Myocardial adipose triglycerid ...... t of lipotoxic cardiomyopathy.
@en
P2093
Erin E Kershaw
Gregory Korbutt
Jason R B Dyck
Jeevan Nagendran
Martin E Young
Terri J Waller
P2860
P304
P356
10.2337/DB12-0927
P407
P577
2013-01-24T00:00:00Z